PRESS RELEASE !!
September 16 11:27 AM EDT
Company Press Release
Weider and Nutraceutix to Market Anti-carcinogenic
Nutritional Supplement
SALT LAKE CITY--(BUSINESS WIRE)-Sept. 16, 1997--Weider Nutrition International Inc.
(NYSE:WNI) announced today that it had entered into a licensing agreement with Nutraceutix Inc.
(OTC BB:NUTX) for the distribution of a nutritional supplement containing the patented chemical
compound glucarate. Current studies funded by the National Cancer Institute indicate that glucarate
may provide effective protection against exposure to many chemical carcinogens such as cigarette
smoke.(1)
Found naturally in fruits and vegetables, glucarate may enhance the body's capacity to resist many
types of carcinogens and toxins. It may in part be responsible for the cancer preventative
characteristics of fruits and vegetables. According to Thomas J. Slaga, Ph.D., director of cancer
cause and prevention, AMC Cancer Center, Denver, Colo., there is strong scientific evidence that
glucarate prevents chemically induced cancers.
``I would recommend glucarate to ex-smokers and women with a family history of breast cancer as
well as anyone at a higher than average risk of developing cancer,'' said Slaga, former director of
cancer cause and prevention at the University of Texas, MD Anderson Cancer Center Science Park
- Research Division.
``This is an ideal collaboration because of Weider's strong retail distribution, advertising and
promotional resources and Nutraceutix strong technical and proprietary position with regard to
glucarate,'' said Richard Bizzaro, president and CEO of Weider Nutrition International Inc. ``By
offering innovative products backed up by extensive research, Weider strives to provide
supplements of maximum benefit to the increasingly health- and supplement-conscious American
public.''
The unique formulation of natural compounds and antioxidants found in glucarate may provide some
protection against the harmful effects of the dangerous chemicals in products such as cigarettes,
cigars, pipe tobacco, chewing tobacco and snuff.
Glucarate will be available nationwide in easy-to-swallow capsules and tablets in November.
Packages of glucarate ex-smokers formula will be available in 30- and 60-day supplies at an
approximate price of $11.99 and $19.99 respectively. A glucarate breast support formula will also
be available in a 60-day supply for approximately $19.99.
According to the American Cancer Society, smoking is the primary cause of lung cancer, which will
kill an estimated 160,400 people in 1997. Studies have shown that smoking cessation alone does
not significantly reduce the risk of cancer until 20 years after quitting. It is also estimated that the
number of deaths caused by breast cancer this year will be as high as 44,190.
SS. |
